{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:03Z","timestamp":1740136323975,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>A refractory chronic migraine (RCM) accompanied by medication-overuse headache (MOH) is an extremely disabling disease. Evidence suggests that in selected patients, chronic opioids may be a valuable therapeutic option for RCM. The aim of the present study was to evaluate the effectiveness and safety of prophylaxis with low-dose methadone (LDM) in patients affected by RCM with continuous headache and MOH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective cohort study was performed between May 2012 and November 2015 at the Headache Center and Toxicology Unit of the Careggi University Hospital. Eligible patients were treated with prophylactic LDM and followed up for 12\u00a0months. Headache exacerbations, pain intensity, use of rescue medications, and occurrence of adverse drug reactions (ADRs) were recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty patients (24 females, median age 48\u00a0years) were enrolled. Nineteen (63%) patients dropped out, mainly because of early ADRs (<jats:italic>n<\/jats:italic>\u2009=\u200910), including nausea, vomiting, and constipation. At last available follow-up, LDM was associated with a significant decrease in the number of headache attacks\/month (from a median of 45 (interquartile range 30\u2013150) to 16 (5\u201330), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), in pain intensity (from 8.5 (8\u20139) to 5 (3\u20136), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and in the number of rescue medications consumed per month (from 95 (34\u2013240) to 15 (3\u201328), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). No misuse or diversion cases were observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>LDM could represent a valuable and effective option in selected patients affected by RCM with continuous headache and MOH, although the frequency of early ADRs poses major safety concerns. Randomized controlled trials are needed to confirm the efficacy and safety of LDM prophylaxis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10072-020-04602-3","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T19:03:26Z","timestamp":1595271806000},"page":"987-994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-430X","authenticated-orcid":false,"given":"Silvia","family":"Benemei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Lupi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"De Cesaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niccol\u00f2","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Bettiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierangelo","family":"Geppetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pracucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brunella","family":"Occupati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Mannaioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"4602_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"4602_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1468-2982.2009.01941.x","volume":"30","author":"JL Natoli","year":"2010","unstructured":"Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30:599\u2013609. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01941.x","journal-title":"Cephalalgia"},{"key":"4602_CR3","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/j.1526-4610.2010.01764.x","volume":"50","author":"SD Silberstein","year":"2010","unstructured":"Silberstein SD, Dodick DW, Pearlman S (2010) Defining the pharmacologically intractable headache for clinical trials and clinical practice. Headache 50:1499\u20131506. https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01764.x","journal-title":"Headache"},{"key":"4602_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1129-2377-15-47","volume":"15","author":"P Martelletti","year":"2014","unstructured":"Martelletti P, Katsarava Z, Lampl C, Magis D, Bendtsen L, Negro A, Russell MB, Mitsikostas DD, Jensen RH (2014) Refractory chronic migraine: a consensus statement on clinical definition from the European headache federation. J Headache Pain 15:47. https:\/\/doi.org\/10.1186\/1129-2377-15-47","journal-title":"J Headache Pain"},{"key":"4602_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1468-1331.2010.03094.x","volume":"18","author":"RB Grande","year":"2011","unstructured":"Grande RB, Aaseth K, Benth J\u0160, Lundqvist C, Russell MB (2011) Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol 18:129\u2013137. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03094.x","journal-title":"Eur J Neurol"},{"key":"4602_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/j.1526-4610.2012.02191.x","volume":"52","author":"SB Munksgaard","year":"2012","unstructured":"Munksgaard SB, Bendtsen L, Jensen RH (2012) Treatment-resistant medication overuse headache can be cured. Headache 52:1120\u20131129. https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02191.x","journal-title":"Headache"},{"key":"4602_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0333102414521508","volume":"34","author":"C Tassorelli","year":"2014","unstructured":"Tassorelli C, Jensen R, Allena M, De Icco R, Sances G, Katsarava Z, Lainez M, Leston J, Fadic R, Spadafora S, Pagani M, Nappi G, The COMOESTAS Consortium (2014) A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study. Cephalalgia 34:645\u2013655. https:\/\/doi.org\/10.1177\/0333102414521508","journal-title":"Cephalalgia"},{"key":"4602_CR8","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/j.1468-2982.2006.01190.x","volume":"26","author":"P Zeeberg","year":"2006","unstructured":"Zeeberg P, Olesen J, Jensen R (2006) Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 26:1192\u20131198","journal-title":"Cephalalgia"},{"key":"4602_CR9","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1212\/01.wnl.0000125189.17830.02","volume":"62","author":"JR Saper","year":"2004","unstructured":"Saper JR, Lake AE 3rd, Hamel RL, Lutz TE, Branca B, Sims DB, Kroll MM (2004) Daily scheduled opioids for intractable head pain: long-term observations of a treatment program. Neurology 62:1687\u20131694. https:\/\/doi.org\/10.1212\/01.wnl.0000125189.17830.02","journal-title":"Neurology"},{"key":"4602_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","volume":"10","author":"R Chou","year":"2009","unstructured":"Chou R, Fanciullo GJ, JA FPGA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C, American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10:113\u2013130. https:\/\/doi.org\/10.1016\/j.jpain.2008.10.008","journal-title":"J Pain"},{"key":"4602_CR11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1526-4610.2008.01153.x","volume":"48","author":"JR Saper","year":"2008","unstructured":"Saper JR, Lake AE (2008) Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines. Headache 48:838\u2013849. https:\/\/doi.org\/10.1111\/j.1526-4610.2008.01153.x","journal-title":"Headache"},{"key":"4602_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/pgmj.2004.022988","volume":"80","author":"R Brown","year":"2004","unstructured":"Brown R, Kraus C, Fleming M, Reddy S (2004) Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J 80:654\u2013659","journal-title":"Postgrad Med J"},{"issue":"7","key":"4602_CR13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1399-6576.2008.01597.x","volume":"52","author":"OMS Fredheim","year":"2008","unstructured":"Fredheim OMS, Moksnes K, Borchgrevink PC, Kaasa S, Dale O (2008) Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand 52(7):879\u2013889. https:\/\/doi.org\/10.1111\/j.1399-6576.2008.01597.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"4602_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(97)13392-4","volume":"223","author":"AL Gorman","year":"1997","unstructured":"Gorman AL, Elliott KJ, Inturrisi CE (1997) The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett 223:1\u20134","journal-title":"Neurosci Lett"},{"key":"4602_CR15","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1124\/mol.108.048512","volume":"74","author":"S Arttamangkul","year":"2008","unstructured":"Arttamangkul S, Quillinan N, Low MJ, von Zastrow M, Pintar J, Williams JT (2008) Differential activation and trafficking of mu-opioid receptors in brain slices. Mol Pharmacol 74:972\u2013979. https:\/\/doi.org\/10.1124\/mol.108.048512","journal-title":"Mol Pharmacol"},{"key":"4602_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/jpm.2012.0612","volume":"16","author":"SR Salpeter","year":"2013","unstructured":"Salpeter SR, Buckley JS, Bruera E (2013) The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med 16:616\u2013622. https:\/\/doi.org\/10.1089\/jpm.2012.0612","journal-title":"J Palliat Med"},{"key":"4602_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0885-3924(03)00258-6","volume":"26","author":"S Mercadante","year":"2003","unstructured":"Mercadante S, Ferrera P, Villari P, Arcuri E (2003) Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manag 26:769\u2013775","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"4602_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pharmthera.2007.10.003","volume":"117","author":"T Koch","year":"2008","unstructured":"Koch T, H\u00f6llt V (2008) Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther 117(2):199\u2013206. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.10.003","journal-title":"Pharmacol Ther"},{"key":"4602_CR19","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1111\/bcp.13326","volume":"83","author":"GK Isbister","year":"2017","unstructured":"Isbister GK, Brown AL, Gill A, Scott AJ, Calver L, Dunlop AJ (2017) QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings. Br J Clin Pharmacol 83:2274\u20132282. https:\/\/doi.org\/10.1111\/bcp.13326","journal-title":"Br J Clin Pharmacol"},{"key":"4602_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00540-013-1785-3","volume":"28","author":"JO Neto","year":"2014","unstructured":"Neto JO, Machado MD, de Almeida CM, Scomparim HA, Posso IP, Ashmawi HA (2014) Methadone patient-controlled analgesia for postoperative pain: a randomized, controlled, double-blind study. J Anesth 28:505\u2013510. https:\/\/doi.org\/10.1007\/s00540-013-1785-3","journal-title":"J Anesth"},{"key":"4602_CR21","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/papr.12535","volume":"17","author":"R Rauck","year":"2017","unstructured":"Rauck R, Slatkin NE, Stambler N, Harper JR, Israel RJ (2017) Randomized, double-blind trial of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic noncancer pain. Pain Pract 17:820\u2013828. https:\/\/doi.org\/10.1111\/papr.12535","journal-title":"Pain Pract"},{"issue":"4","key":"4602_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ajem.2019.06.001","volume":"38","author":"R Daoust","year":"2019","unstructured":"Daoust R, Paquet J, Cournoyer A, Piette \u00c9, Morris J, Lessard J, Castongua V, Williamson D, Chauny JM (2019) Side effects from opioids used for acute pain after emergency department discharge. Am J Emerg Med 38(4):695\u2013701. https:\/\/doi.org\/10.1016\/j.ajem.2019.06.001","journal-title":"Am J Emerg Med"},{"issue":"3","key":"4602_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/AJP.0b013e31815d3619","volume":"24","author":"PE Bijur","year":"2008","unstructured":"Bijur PE, Esses D, Birnbaum A, Chang AK, Schechter C, Gallagher EJ (2008) Response to morphine in male and female patients: analgesia and adverse events. Clin J Pain 24(3):192\u2013198. https:\/\/doi.org\/10.1097\/AJP.0b013e31815d3619","journal-title":"Clin J Pain"},{"issue":"3","key":"4602_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1053\/ajem.2002.32631","volume":"20","author":"LS Zun","year":"2002","unstructured":"Zun LS, Downey LVA, Gossman W, Rosenbaumdagger J, Sussman G (2002) Gender differences in narcotic-induced emesis in the ED. Am J Emerg Med 20(3):151\u2013154. https:\/\/doi.org\/10.1053\/ajem.2002.32631","journal-title":"Am J Emerg Med"},{"issue":"2","key":"4602_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpain.2004.11.005","volume":"6","author":"RB Fillingim","year":"2005","unstructured":"Fillingim RB, Ness TJ, Glover TL, Campbell CM, Hastie BA, Price DD, Staud R (2005) Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia. J Pain 6(2):116\u2013124. https:\/\/doi.org\/10.1016\/j.jpain.2004.11.005","journal-title":"J Pain"},{"issue":"2","key":"4602_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0009-9236(03)00152-8","volume":"74","author":"MS Cepeda","year":"2003","unstructured":"Cepeda MS, Farrar JT, Baumgarten M, Boston R, Carr DB, Strom BL (2003) Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther 74(2):102\u2013112. https:\/\/doi.org\/10.1016\/S0009-9236(03)00152-8","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"4602_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1155\/2015\/316275","volume":"20","author":"R Daoust","year":"2015","unstructured":"Daoust R, Paquet J, Lavigne G, Piette \u00c9, Chauny JM (2015) Impact of age, sex and route of administration on adverse events after opioid treatment in the emergency department: a retrospective study. Pain Res Manag 20(1):23\u201328. https:\/\/doi.org\/10.1155\/2015\/316275","journal-title":"Pain Res Manag"},{"key":"4602_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/brain\/awh691","volume":"129","author":"A Fumal","year":"2006","unstructured":"Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M, Coppola G, Salmon E, Kupers R, Schoenen J (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129:543\u2013550. https:\/\/doi.org\/10.1093\/brain\/awh691","journal-title":"Brain"},{"key":"4602_CR29","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1111\/j.1526-4610.2007.00904.x","volume":"47","author":"JF Rothrock","year":"2007","unstructured":"Rothrock JF (2007) Lagniappe. Headache 47:1232\u20131233","journal-title":"Headache"},{"key":"4602_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1126\/science.aal2943","volume":"354","author":"DS Burke","year":"2016","unstructured":"Burke DS (2016) Forecasting the opioid epidemic. Science 354:529","journal-title":"Science"},{"key":"4602_CR31","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","volume":"387","author":"S Berterame","year":"2016","unstructured":"Berterame S, Erthal J, Thomas J, Fellner S, Vosse B, Clare P, Hao W, Johnson DT, Mohar A, Pavadia J, Samak AK, Sipp W, Sumyai V, Suryawati S, Toufiq J, Yans R, Mattick RP (2016) Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 387:1644\u20131656. https:\/\/doi.org\/10.1016\/S0140-6736(16)00161-6","journal-title":"Lancet"},{"key":"4602_CR32","doi-asserted-by":"publisher","first-page":"E659","DOI":"10.1503\/cmaj.170363","volume":"189","author":"JW Busse","year":"2017","unstructured":"Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, Cull C, da Costa BR, Frank JW, Grant G, Iorio A, Persaud N, Stern S, Tugwell P, Vandvik PO, Guyatt GH (2017) Guideline for opioid therapy and chronic noncancer pain. CMAJ 189:E659\u2013E666. https:\/\/doi.org\/10.1503\/cmaj.170363","journal-title":"CMAJ"},{"key":"4602_CR33","doi-asserted-by":"publisher","first-page":"g6802","DOI":"10.1136\/bmj.g6802","volume":"349","author":"JJ Gagne","year":"2014","unstructured":"Gagne JJ, Thompson L, O'Keefe K, Kesselheim AS (2014) Innovative research methods for studying treatments for rare diseases: methodological review. BMJ 349:g6802. https:\/\/doi.org\/10.1136\/bmj.g6802","journal-title":"BMJ"},{"issue":"3","key":"4602_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1965","volume":"3","author":"AA Mitani","year":"2020","unstructured":"Mitani AA, Haneuse S (2020) Small data challenges of studying rare diseases. JAMA Netw Open 3(3):e201965. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.1965","journal-title":"JAMA Netw Open"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04602-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04602-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04602-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:04:43Z","timestamp":1626739483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04602-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4602"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04602-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Ethics Committee on Clinical Research (<i>Comitato Etico Regione Toscana, Sezione Area Vasta Centro; approval number 6078<\/i>) and registered in the Italian Registry for Observational Studies held by the Italian Medicines Agency (AIFA).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"An informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed an informed consent regarding publishing their data, in an aggregated and anonymous form.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}